Trial Profile
Effects of aripiprazole on the steady-state pharmacokinetics of venlafaxine in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Nov 2013
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Venlafaxine (Primary)
- Indications Affective disorders; Generalised anxiety disorder; Major depressive disorder; Panic disorder; Psychotic disorders; Social phobia
- Focus Pharmacokinetics
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 16 Nov 2006 New trial record.